PMA device
Ancure Endograft System
Boston Scientific Corp · System, Endovascular Graft, Aortic Aneurysm Treatment (MIH, Class III) · First FDA decision Apr 14, 2000, newest Jan 2, 2003Aortic aneurysm and dissection
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
15
PMA pathway
Device trials
0
Naming "Ancure Endograft"
MAUDE reports
13
Brand "Ancure Endograft", since 2015
PubMed studies
9
Mentioning "Ancure Endograft"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ancure Endograft System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 15 decisions filed under this name.
- ANCURE ENDOGRAFT SYSTEMPMA supplement
P990017-S037 · Decided Jan 2, 2003 · 36 days after receipt · Normal 180 Day Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- ANCURE ENDOGRAFT SYSTEMPMA supplement
P990017-S035 · Decided Sep 10, 2002 · 26 days after receipt · Normal 180 Day Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- ANCURE ENDOGRAFT SYSTEMPMA supplement
P990017-S032 · Decided Jul 25, 2002 · 45 days after receipt · Normal 180 Day Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
3 more FDA decisions with a free account
Older decisions: P990017-S025, P990017-S023, P990017-S021, P990017-S020, P990017-S017, P990017-S016, P990017-S015, P990017-S009, P990017-S006
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower ExtremitiesLocal determinationIn effectL36377First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Ancure Endograft", any status and sponsor, newest update first.
No registered device study names "Ancure Endograft".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ancure Endograft", and for the whole product code for context.
This brand
13 reports: 2 malfunction, 11 injury, 0 death
Whole product code MIH
43,674 reports: 7,807 malfunction, 32,331 injury, 3,518 death
Newest reports for this brand
GUIDANT ENDOVASCULAR SOLUTIONS
2954310-2021-81833 · Received Oct 20, 2021
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Device problem as coded: Leak/Splash
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ANCURE ENDOGRAFT (FORMERLY EVT ENDOGRAFT)Malfunction
GUIDANT ENDOVASCULAR SOLUTIONS
2954310-2021-81832 · Received Oct 20, 2021 · Event dated Mar 12, 2014
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Device problem as coded: Leak/Splash
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
GUIDANT ENDOVASCULAR SOLUTIONS
2954310-2016-81831 · Received May 19, 2016 · Event dated May 30, 2014
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Device problem as coded: Leak/Splash; Appropriate Device Problem Term/Code Not Available
Patient problem as coded: Thrombus; No Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Ancure Endograft"[tiab]. The summary above synthesizes these.
- Endovascular treatment of iliac limb stenoses or occlusions in 31 patients treated with the ancure endograft.
Amesur NB, Zajko AB, Orons PD, et al. · J Vasc Interv Radiol · 2000Clinical Trial, Clinical Trial, Phase II
- Does the type of endograft affect AAA volume change after endovascular aneurysm repair?
van der Laan MJ, Prinssen M, Bertges D, et al. · J Endovasc Ther · 2003Comparative Study, Multicenter Study
- Does endograft support alter the rate of aneurysm sac shrinkage after endovascular repair?
Rhee RY, Garvey L, Missig-Carroll N, et al. · J Endovasc Ther · 2003Comparative Study
- Fabric tears as a new cause of type III endoleak with Ancure endograft.
Teutelink A, van der Laan MJ, Milner R, et al. · J Vasc Surg · 2003Case Reports, Research Support, Non-U.S. Gov't
- Detection of isolated hook fractures 36 months after implantation of the Ancure endograft: a cautionary note.
Najibi S, Steinberg J, Katzen BT, et al. · J Vasc Surg · 2001Case Reports, Research Support, Non-U.S. Gov't
- Endovascular repair of the abdominal aortic aneurysm with the ancure endograft: CT follow-up of perigraft flow and aneurysm size at 6 months.
Franco TJ, Zajko AB, Federle MP, et al. · J Vasc Interv Radiol · 2000
- "Unpredictable" late rupture of an abdominal aortic aneurysm after bifurcated Ancure endograft repair.
Rosen NA, Cayne NS, Macari M, et al. · Vasc Endovascular Surg · 2008Case Reports
- Duplex ultrasound as the sole long-term surveillance method post-endovascular aneurysm repair: a safe alternative for stable aneurysms.
Chaer RA, Gushchin A, Rhee R, et al. · J Vasc Surg · 2009Evaluation Study
- Treatment of a primary type IA endoleak with a liquid embolic system under conditions of aortic occlusion.
Kirby L, Goodwin J · J Vasc Surg · 2003Case Reports
Other devices of this type
Also filed under product code MIH.
- GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1W. L. Gore & Associates, Inc. · PMA 2026
- Aneurx Stent Graft SystemMedtronic Vascular · PMA 2011
- Talent Thoracic Stent Graft SystemMedtronic Vascular · PMA 2016
- GORE EXCLUDER AAA Endoprosthesis product familyW. L. Gore & Associates, Inc. · PMA 2021
- Talent Abdominal Stent Graft SystemMedtronic Vascular · PMA 2014
- TREO® Abdominal Stent-Graft SystemBolton Medical, Inc. · PMA 2026
- Zenith Fenestrated AAA Endovascular GraftCook, Inc. · PMA 2022
- Powerlink System with Intuitrak Delivery SystemEndologix, LLC · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.